How Massive Bio’s Reticulum Nexus suite is targeting the hidden bottlenecks in cancer trials
Can Massive Bio’s Reticulum Nexus suite close oncology trial access gaps? Find out how AI agents may reshape cancer trial navigation today!
FDA breakthrough status gives Coredio’s AI heart failure platform a faster regulatory path
Coredio’s AI heart failure platform may bring hemodynamic insight into home care. See why FDA breakthrough status matters now.
A workers’ comp portal may not sound flashy. For orthopaedic care delays, it could matter
Find out how DMOS Orthopaedic Centers’ new workers’ comp portal could speed referrals, reduce delays and improve injury-care coordination.
Phoenix and Raven launch direct-to-patient generic semaglutide after Health Canada approval
Generic semaglutide is cheaper, but access is now the real battleground. Phoenix and Raven are testing Canada’s GLP-1 telehealth future.
Why Glooko’s FDA-cleared EndoTool IV Cloud could reshape hospital glycemic management
Insulin dosing is moving to the cloud. Glooko’s FDA clearance raises bigger questions on hospital workflow, safety, and scale.
Can Biozen turn cuffless blood pressure from medtech promise into clinical reality?
Cuffs are accurate but inconvenient. Biozen’s FDA-cleared BP1000 tests whether fingertip blood pressure checks can change hypertension care.
Is WHOOP quietly turning its fitness band into a front door for healthcare?
Wearables collect more health data than ever. WHOOP is betting clinicians and AI can turn that flood into real decisions.
Why Sequenex’s MedTech Innovator partnership matters for connected device startups
Medtech startups have sensors, but software can slow them down. Sequenex’s MedTech Innovator tie up targets that commercialization gap.
Can Earflo reduce ear tube surgery pressure with its FDA-cleared pediatric device?
Pediatric ear care has long had a waiting-room problem. Earflo’s FDA-cleared device tests whether home therapy can close the gap.
Can Teva Pharmaceutical Industries Ltd.’s Home Ground platform reshape schizophrenia support beyond medication?
Read how Teva Pharmaceutical Industries Ltd.’s Home Ground may reshape schizophrenia support, adherence, and care pathways. Discover what changes next.